72 related articles for article (PubMed ID: 2459727)
1. [Test of the potency of trivalent oral polio vaccines: comparison of 2 methods of reading].
Chocarro LB; Manau MV
Rev Argent Microbiol; 1987; 19(2):65-9. PubMed ID: 2459727
[TBL] [Abstract][Full Text] [Related]
2. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation.
Montagnon BJ; Nicolas AJ; Fanget B; Peyron L
Dev Biol Stand; 1981; 47():151-5. PubMed ID: 6262146
[TBL] [Abstract][Full Text] [Related]
4. Potency test of inactivated polio vaccines in guinea pigs.
Lapinleimu K; Stenvik M
Dev Biol Stand; 1981; 47():109-12. PubMed ID: 7014296
[TBL] [Abstract][Full Text] [Related]
5. Present state and developments in the production of inactivated poliomyelitis vaccine.
van Wezel AL
Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
[TBL] [Abstract][Full Text] [Related]
6. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
[TBL] [Abstract][Full Text] [Related]
7. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
[TBL] [Abstract][Full Text] [Related]
8. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
9. Preliminary results on the use of human diploid fibroblasts for inactivated polio virus vaccine production.
Larsson B; Litwin J
Dev Biol Stand; 1980; 46():241-7. PubMed ID: 6245000
[TBL] [Abstract][Full Text] [Related]
10. [The immunological basis of the administration of DTP-polio vaccine].
Cohen H
Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
[TBL] [Abstract][Full Text] [Related]
11. Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype.
Mo C; Yamagata R; Pan A; Reddy J; Hazari N; Duke G
J Virol Methods; 2008 Jun; 150(1-2):63-9. PubMed ID: 18423899
[TBL] [Abstract][Full Text] [Related]
12. Poliomyelitis vaccines: an appraisal after 25 years.
Melnick JL
Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
[No Abstract] [Full Text] [Related]
13. Use of Crystal Violet to Improve Visual Cytopathic Effect-based Reading for Viral Titration using TCID50 Assays.
Frias-De-Diego A; Crisci E
J Vis Exp; 2022 Feb; (180):. PubMed ID: 35225281
[TBL] [Abstract][Full Text] [Related]
14. Current advances in viral diagnostic technology applicable to polio vaccination and diagnosis.
Chernesky MA
Rev Infect Dis; 1984; 6 Suppl 2():S525-7. PubMed ID: 6330851
[TBL] [Abstract][Full Text] [Related]
15. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
[TBL] [Abstract][Full Text] [Related]
16. Stabilizing effect of magnesium chloride and sucrose on Sabin live polio vaccine.
Mirchamsy H; Shafyi A; Mahinpour M; Nazari P
Dev Biol Stand; 1978; 41():255-7. PubMed ID: 223912
[TBL] [Abstract][Full Text] [Related]
17. Effects of iodized oil on trivalent oral polio vaccine in vitro.
Bruning JH; van Nimwegen FW; Oostvogel P; van Steenis G; Cohen N
Int J Vitam Nutr Res; 1994; 64(2):125-9. PubMed ID: 7960491
[TBL] [Abstract][Full Text] [Related]
18. The value of potency testing of poliomyelitis and measles vaccines as an integral part of cold chain surveillance.
Saraswathy TS; Sinniah M; Lee WS; Lee PC
Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):265-8. PubMed ID: 8266228
[TBL] [Abstract][Full Text] [Related]
19. Rat immunogenicity assay of inactivated poliovirus.
Bevilacqua JM; Young L; Chiu SW; Sparkes JD; Kreeftenberg JG
Dev Biol Stand; 1996; 86():121-7. PubMed ID: 8785941
[TBL] [Abstract][Full Text] [Related]
20. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after.
Lasch EE; Abed Y; Marcus O; Gerichter CB; Melnick JL
Dev Biol Stand; 1986; 65():137-43. PubMed ID: 3556771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
